Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07308743Not ApplicableNot Yet Recruiting

Impact of Computer-aided Detection System on the Proximal Adenoma Miss Rate

Role: collaborator

NCT04974138Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

Role: collaborator

NCT04974151Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

Role: collaborator

NCT04212494Not ApplicableRecruiting

Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Role: collaborator

NCT05769712Unknown

A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity

Role: collaborator

NCT03928119Not ApplicableUnknown

reGional Network for Acute Myocardial Infarction

Role: collaborator

NCT05050877Completed

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Role: collaborator

All 7 trials loaded